Leptin as a Potential Modifier of Neuroinflammation: Contrasting Roles in Alzheimer’s Disease and Multiple Sclerosis
Naghmeh Abbasi Kasbi, Barbara Elena Stopschinski, Alanna Gabrielle Polyak, Agastya Reddy Malladi, Navid Manouchehri, Philipp E. Scherer, Olaf Stuve · 2025
Read Leptin as a Potential Modifier of Neuroinflammation: Contrasting Roles in Alzheimer’s Disease and Multiple Sclerosis by Naghmeh Abbasi Kasbi, Barbara Elena Stopschinski, Alanna Gabrielle Polyak, Agastya Reddy Malladi, Navid Manouchehri, Philipp E. Scherer, Olaf Stuve (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12785794.txt.
Description
Naghmeh Abbasi Kasbi and six co-authors offer a 2025 review of leptin, a hormone best known for controlling appetite and body energy use. The hormone also acts on immune cells and shapes swelling in the brain and nerves. The review compares its role in two diseases: multiple sclerosis, an immune attack on nerve coverings, and Alzheimer's disease, a slow loss of memory and thinking.
The authors find leptin's pattern runs in opposite directions in the two diseases. Levels tend to rise in multiple sclerosis, more so during flare-ups, and push immune cells toward attack. In Alzheimer's disease, levels tend to fall, and that drop links to the protein buildup that marks the illness. Obesity complicates both pictures, since excess leptin can blunt its helpful signals. The review calls for more long-term studies of this two-way effect.
Catalog record
| CREATOR | Naghmeh Abbasi Kasbi, Barbara Elena Stopschinski, Alanna Gabrielle Polyak, Agastya Reddy Malladi, Navid Manouchehri, Philipp E. Scherer, Olaf Stuve |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 138 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |